Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05618041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Sep 6, 2024 to Sep 6, 2027 Trial status: Completed to Recruiting · Enrollment target: 42 to 50 · Completion date: Dec 6, 2024 to Dec 6, 2027 · 2 morev6 Show 5 more changesShow less
    • Trial status: Completed to Recruiting
    • Enrollment target: 42 to 50
    • Completion date: Dec 6, 2024 to Dec 6, 2027
    • Site details revised
    • Collaborators expanded, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Recruiting to Completed Enrollment target: estimated 50 to confirmed 42 · Site details revisedv5 Show 2 more changesShow less
    • Enrollment target: estimated 50 to confirmed 42
    • Site details revised
  3. Study title expanded, about 2 wordsv4 See this version in full on ClinicalTrials.gov ↗
  4. Site contact updatedv3
  5. Study site revisedv2 See this version in full on ClinicalTrials.gov ↗
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the tolerability and safety of CAR-T technology in patients with relapsed or refractory hematolymphoid malignancies.
Trial Details
NCT Number NCT05618041
Lead Sponsor Hebei Senlang Biotechnology Inc., Ltd.
Collaborators: Hebei Taihe Chunyu Biotechnology Co., Ltd
Conditions Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov